ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.540
-0.040 (-2.53%)
At close: Jul 31, 2026, 4:00 PM EDT
1.520
-0.020 (-1.30%)
After-hours: Jul 31, 2026, 7:56 PM EDT
ProKidney Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 101.9 | 108.54 | 99.12 | 60.65 | 490.25 | 20.56 |
Short-Term Investments | 123.05 | 161.48 | 259.17 | 302.3 | - | - |
Cash & Short-Term Investments | 224.94 | 270.02 | 358.29 | 362.95 | 490.25 | 20.56 |
Cash Growth | -31.52% | -24.64% | -1.28% | -25.97% | 2284.73% | 349.06% |
Other Receivables | 1.03 | 1.13 | 2.45 | 1.38 | - | - |
Total Trade Receivables | 1.03 | 1.13 | 2.45 | 1.38 | - | - |
Other Current Assets | 8.93 | 9.54 | 35.15 | 9.82 | 14.47 | 6.71 |
Total Current Assets | 234.9 | 280.68 | 395.88 | 374.15 | 504.72 | 27.27 |
Net Property, Plant & Equipment | 57.88 | 54.9 | 45.19 | 46.41 | 13.06 | 12.6 |
Other Intangible Assets | - | - | - | - | 0.21 | 0.43 |
Total Assets | 292.78 | 335.57 | 441.07 | 420.55 | 518 | 40.3 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.59 | 0.94 | 3.63 | 5.1 | 3.04 | 2.83 |
Accrued Expenses | 22.23 | 28.73 | 31.14 | 17.67 | 7.34 | 9.21 |
Current Portion of Leases | 1.11 | 1.07 | 0.77 | 0.8 | 0.49 | 0.27 |
Other Current Liabilities | - | - | 0.68 | 1.47 | - | - |
Total Current Liabilities | 25.93 | 30.74 | 36.22 | 25.04 | 10.87 | 12.31 |
Long-Term Leases | 2.68 | 2.97 | 2.47 | 3.61 | 1.91 | 1.07 |
Other Long-Term Liabilities | 1.07 | 1.07 | 0.75 | 0.57 | 0.28 | - |
Total Long-Term Liabilities | 3.75 | 4.04 | 3.22 | 4.18 | 2.18 | 1.07 |
Total Liabilities | 29.68 | 34.78 | 39.44 | 29.22 | 13.06 | 13.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 188.43 |
Additional Paid-in Capital | 266.11 | 258.55 | 205.74 | 36.11 | 7.48 | - |
Accumulated Other Comprehensive Income | -0.05 | 0.06 | 0.13 | 0.13 | - | - |
Retained Earnings | -1,290 | -1,270 | -1,201 | -1,140 | -1,104 | -161.51 |
Total Common Shareholders' Equity | -1,024 | -1,011 | -994.95 | -1,103 | -1,097 | 26.92 |
Minority Interest | 1,287 | 1,312 | 1,397 | 1,495 | 1,602 | - |
Shareholders' Equity | 263.1 | 300.79 | 401.64 | 391.34 | 504.94 | 26.92 |
Total Liabilities & Equity | 292.78 | 335.57 | 441.07 | 420.55 | 518 | 40.3 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.78 | 4.04 | 3.24 | 4.41 | 2.4 | 1.33 |
Net Cash (Debt) | 221.16 | 265.98 | 355.06 | 358.54 | 487.85 | 19.22 |
Net Cash Growth | -31.98% | -25.09% | -0.97% | -26.51% | 2437.73% | 536.77% |
Net Cash Per Share | 1.61 | 1.99 | 3.63 | 5.81 | 7.93 | 0.13 |
Book Value | -1,024 | -1,011 | -994.95 | -1,103 | -1,097 | 26.92 |
Book Value Per Share | -7.46 | -7.55 | -10.16 | -17.88 | -17.82 | 0.18 |
Tangible Book Value | -1,024 | -1,011 | -994.95 | -1,103 | -1,097 | 26.49 |
Tangible Book Value Per Share | -7.46 | -7.55 | -10.16 | -17.88 | -17.82 | 0.18 |